Transgenic rabbits as therapeutic protein bioreactors and human disease models.
about
Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicineUse of Transgenic Animals to Improve Human Health and Animal ProductionTransgenic rabbits with increased VEGF expression develop hemangiomas in the liver: a new model for Kasabach-Merritt syndrome.Animal models of C-reactive protein.Recombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis.Beneficial effect of young oocytes for rabbit somatic cell nuclear transferHuman C-reactive protein does not promote atherosclerosis in transgenic rabbits.Generation of induced pluripotent stem cells in rabbits: potential experimental models for human regenerative medicine.Xist deficiency and disorders of X-inactivation in rabbit embryonic stem cells can be rescued by transcription-factor-mediated conversion.Bisphenol A exposure enhances atherosclerosis in WHHL rabbits.Transgenic fish systems and their application in ecotoxicology.A rabbit model of thrombosis on atherosclerotic lesions.Rosiglitazone attenuates atherosclerosis and increases high-density lipoprotein function in atherosclerotic rabbits.Urotensin II promotes atherosclerosis in cholesterol-fed rabbits.Spatial and temporal distribution of Oct-4 and acetylated H4K5 in rabbit embryos.Combined use of probucol and cilostazol with atorvastatin attenuates atherosclerosis in moderately hypercholesterolemic rabbits.Recombinant rabbit leukemia inhibitory factor and rabbit embryonic fibroblasts support the derivation and maintenance of rabbit embryonic stem cells.Dynamic profiles of Oct-4, Cdx-2 and acetylated H4K5 in in-vivo-derived rabbit embryos.Autocrine Human Urotensin II Enhances Macrophage-Derived Foam Cell Formation in Transgenic Rabbits.Derivation of Rabbit Embryonic Stem Cells from Vitrified-Thawed Embryos.Rabbit Models for Studying Human Infectious Diseases.Endothelial lipase mediates HDL levels in normal and hyperlipidemic rabbits.Transgenic rabbit models for studying human cardiovascular diseases.LaGomiCs-Lagomorph Genomics Consortium: An International Collaborative Effort for Sequencing the Genomes of an Entire Mammalian OrderThe genetic structure of domestic rabbitsDecreased expression of surfactant protein genes is associated with an increased expression of Forkhead box M1 gene in the fetal lung tissues of premature rabbits.Apolipoprotein CI is a physiological regulator of cholesteryl ester transfer protein activity in human plasma but not in rabbit plasma.Generation of SV40-transformed rabbit tracheal-epithelial-cell-derived blastocyst by somatic cell nuclear transfer.Production of apolipoprotein C-III knockout rabbits using zinc finger nucleases.Roles of the WHHL rabbit in translational research on hypercholesterolemia and cardiovascular diseases.The use of genetic engineering techniques to improve the lipid composition in meat, milk and fish products: a review.C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance.Expression systems and species used for transgenic animal bioreactors.Bisphenol A exposure induces metabolic disorders and enhances atherosclerosis in hyperlipidemic rabbits.High-level expression of a novel recombinant human plasminogen activator (rhPA) in the milk of transgenic rabbits and its thrombolytic bioactivity in vitro.Candidate gene expression patterns in rabbit preimplantation embryos developed in vivo and in vitro.Effective gene targeting in rabbits using RNA-guided Cas9 nucleases.Overexpression of lipoprotein lipase improves insulin resistance induced by a high-fat diet in transgenic rabbits.Inflammatory responses induced by fluoride and arsenic at toxic concentration in rabbit aorta.Overexpression of lipoprotein lipase in transgenic rabbits leads to increased small dense LDL in plasma and promotes atherosclerosis.
P2860
Q26853133-98788416-7814-4BD0-BA95-10A2AD8AB73FQ29029045-1F8A1DED-9BB1-4EE7-A25F-6D788332C08DQ33368758-7C929E64-489E-448C-9FA3-6045638BC1A9Q33607563-9F0B4225-D9DC-4E93-A7BC-CED05973D817Q33780365-0C1B5DF5-4BEF-457E-A7EF-9AA16F25009DQ33964361-5F317A19-1FA8-40E7-90D9-D74F17E55102Q34021492-7A30BACD-7ACB-4DA1-8336-E7092FAC4CBDQ34181340-EB85363E-E740-4537-BE3D-E49B2E7DE2F6Q34232250-A300D52B-4A06-4F9C-BA51-128FA67C65DDQ34380796-F4EDE0C0-041C-4047-B350-E08FAD691296Q34447763-BF96CF86-9611-4FAB-8789-2A25873B470DQ34495491-A1A48335-694B-42D6-B8BC-93267B44C4A5Q35040072-CAB371E7-860E-4D41-A9A4-0DEC591A8E47Q35152923-F6C9C930-AF7B-4692-BF63-EC2CAB71E87AQ35873749-986A866C-FD0C-4C08-A28C-AFBCA720506EQ35895983-1B10E678-A49E-4F3F-9477-029704F4EAB5Q36138419-B8E2B612-A0D4-42E2-98B3-19283555F6F4Q36301104-B5CEDE1B-5D3D-447B-98CF-3930600C7177Q36320177-FBC7AF04-9AE8-40FE-8F67-873A94C7AA11Q36367824-B9C1B71E-5E14-4320-8140-117F93F959EBQ36376979-2D73CE41-B18C-4DDF-A3F9-1E8EE61AAC76Q36384659-55BD3F9D-3461-4506-9DB9-6C92D172D12CQ36481289-B1B89DC4-CE14-4955-803A-D2C6373CCF6AQ36954998-E9AAF179-D2C4-46BF-ABDF-6AF4C4C84E6FQ36963814-04148376-641A-4985-943C-D4518970803AQ37259508-0DA0CBBE-F50F-4FCC-B87A-0582D9DF3003Q37299858-D13EF25B-4130-47E1-919A-F4391C03C469Q37522146-D27F9297-A795-4C65-9353-0C35FEB3C168Q37709764-4443C605-A2BB-48C0-9BB8-B51F3028773FQ37871868-BB4881D5-A117-4801-9840-5CBB999D8BECQ38286931-CB096BD2-9191-4A54-B5BD-0A2761A03A22Q38596519-A76B3D7E-AC43-45B3-8812-C1120C75DB20Q39468670-8647784A-CD08-4340-AECB-096FDAED4E9FQ40252231-054D1073-87D6-45D9-B8C6-68B9D4F2B069Q40657418-ADC8CDA3-53E3-4912-83F8-F91A3578FC14Q42113811-DE09D909-8E43-4CE3-8248-08A9E6B9CF7DQ42359465-DAB47DDC-09BF-4B98-91BA-E30A79076F0FQ42463841-22E003FA-A6BD-427D-B173-60C7093E042CQ42720473-B73B4265-BC3D-42C2-8AA7-FFDC8734E491Q44879920-4814BC66-0247-4095-A61C-36260E7580A4
P2860
Transgenic rabbits as therapeutic protein bioreactors and human disease models.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Transgenic rabbits as therapeutic protein bioreactors and human disease models.
@ast
Transgenic rabbits as therapeutic protein bioreactors and human disease models.
@en
type
label
Transgenic rabbits as therapeutic protein bioreactors and human disease models.
@ast
Transgenic rabbits as therapeutic protein bioreactors and human disease models.
@en
prefLabel
Transgenic rabbits as therapeutic protein bioreactors and human disease models.
@ast
Transgenic rabbits as therapeutic protein bioreactors and human disease models.
@en
P1476
Transgenic rabbits as therapeutic protein bioreactors and human disease models.
@en
P2093
Jianglin Fan
Teruo Watanabe
P304
P356
10.1016/S0163-7258(03)00069-X
P577
2003-09-01T00:00:00Z